Delivery Order SPE2DB22D1106-SPE2DB25FFAY9
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $5,787.60 delivery order on July 14, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Nemluvio 30 mg pens, with a completion date of September 10, 2025. This delivery order contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens valued at $1,929.20 under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen will perform this pharmaceutical supply delivery from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by October 8, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by October 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of October 10, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a firm fixed price delivery order issued on August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAY9Delivery Order
The Defense Logistics Agency awarded a $7,716.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 21, 2025. This is a non-set-aside, competitively awarded contract reflecting the vendor's capability to meet federal pharmaceutical procurement requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 7/31/25 |